ACC-9653, a prodrug of phenytoin synthesized to be water soluble, is converted to phenytoin by phosphatases. In this study, 43 patients received ACC-9653 IV or IM. Side effects were transient and minor. The conversion half-lives of ACC-9653 after intravenous and intramuscular administration averaged 8.4 and 32.7 minutes, respectively. Peak phenytoin concentrations occurred 42 minutes after IV and 151 minutes after IM administration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1212/wnl.40.3_part_1.456 | DOI Listing |
Publication Analysis
Top Keywords
pharmacokinetics safety
4
phenytoin
4
safety phenytoin
4
phenytoin prodrug
4
prodrug patients
4
patients acc-9653
4
acc-9653 prodrug
4
prodrug phenytoin
4
phenytoin synthesized
4
synthesized water
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!